Cancer conversations are difficult — but clearer ones lead to better outcomes. Articles, guides and updates from Dr. Ammbulkar's practice.
Educational pieces on cancer prevention, screening, treatment and life after diagnosis — written for patients and families.
A simple blood test is increasingly used to detect and monitor cancer. What ctDNA testing actually detects, where it's genuinely useful today, and where it still falls short of a traditional biopsy.
Read the full guide →Where artificial intelligence genuinely helps in oncology today — imaging, treatment planning, patient triage — and where a doctor's judgment still can't be replaced. A plain-language guide for patients.
Read the full guide →What actually matters when choosing a cancer specialist near you — experience, communication, accessibility, and second opinions. A practical guide for patients in Borivali West and surrounding Mumbai.
Read the full guide →Both are CDK4/6 inhibitors used to treat HR-positive, HER2-negative breast cancer — but they are not interchangeable. Different pivotal trial evidence, different approved indications, different side-effect profiles, and very different costs. A patient guide on how to think about the choice.
Read the full guide →The Kerala High Court is hearing a case on whether palbociclib can substitute the more expensive ribociclib for HR-positive, HER2-negative breast cancer. Both belong to the CDK4/6 inhibitor class, but oncologists — Dr. Ammbulkar among those quoted — caution that they differ in approved indications, trial evidence and outcomes. Ribociclib is approved for both early-stage high-risk and metastatic disease with a demonstrated overall survival benefit; palbociclib is approved for metastatic disease only. The choice must remain a clinical decision.
Read the full report →What TNBC actually is, why it is different from other breast cancers, and what current treatment options look like.
Read article →Family history, red flags and the practical steps of a genetic test — and what the results really mean for your health decisions.
Read article →Symptoms that deserve a doctor visit rather than a wait-and-watch — and why early consultation matters.
Read article →A patient-friendly explanation of what immunotherapy is, which cancers it treats, and what to expect during a course.
Read article →Nutrition, movement, mental health and family support — small choices that make a real difference through treatment.
Read article →How targeted therapy is changing outcomes for certain lung cancer subtypes, and who is a candidate.
Read article →More articles coming soon. For video content, subscribe to Dr. Ammbulkar on YouTube.